ECCO IBD Curriculum
16.2. Knows the evidence that supports the use of currently unlicensed therapies in IBD
This course is designed for gastroenterologists, surgeons, paediatricians, pathologists and other interdisciplinary medical experts interested in Inflammatory Bowel Disease(s) (IBD). One major aim of this e-learning activity is to increase competence and knowledge with regard to the prediction, diagnosis and management of stricturing Crohn's Disease (CD) patients and to harmonise diagnostics and treatment in order to improve patient outcomes.
Upon completion of this activity learners will:
- Achieve familiarity with predictors of fibrostenosing CD.
- Understand the role of cross-sectional imaging in the diagnostic work-up of patients with suspected fibrostenosing CD.
- Understand the current management of fibrostenosing CD.
- Recognise the therapeutic capabilities of anti-inflammatory therapy, endoscopic dilatation and surgery in the setting of fibrostenosing CD.